ATE7393T1 - Imidazo(1,2-a)pyridinderivate, verfahren zu ihrer herstellung und ihre therapeutische anwendung. - Google Patents

Imidazo(1,2-a)pyridinderivate, verfahren zu ihrer herstellung und ihre therapeutische anwendung.

Info

Publication number
ATE7393T1
ATE7393T1 AT81401606T AT81401606T ATE7393T1 AT E7393 T1 ATE7393 T1 AT E7393T1 AT 81401606 T AT81401606 T AT 81401606T AT 81401606 T AT81401606 T AT 81401606T AT E7393 T1 ATE7393 T1 AT E7393T1
Authority
AT
Austria
Prior art keywords
imidazo
production
pyridine derivatives
therapeutic application
pyridine
Prior art date
Application number
AT81401606T
Other languages
English (en)
Inventor
Jean-Pierre Kaplan
Pascal George
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9247171&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE7393(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Synthelabo filed Critical Synthelabo
Application granted granted Critical
Publication of ATE7393T1 publication Critical patent/ATE7393T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT81401606T 1980-10-22 1981-10-15 Imidazo(1,2-a)pyridinderivate, verfahren zu ihrer herstellung und ihre therapeutische anwendung. ATE7393T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8022537A FR2492382A1 (fr) 1980-10-22 1980-10-22 Derives d'imidazo (1,2-a) pyridine, leur preparation et leur application en therapeutique
EP81401606A EP0050563B1 (de) 1980-10-22 1981-10-15 Imidazo(1,2-a)pyridinderivate, Verfahren zu ihrer Herstellung und ihre therapeutische Anwendung

Publications (1)

Publication Number Publication Date
ATE7393T1 true ATE7393T1 (de) 1984-05-15

Family

ID=9247171

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81401606T ATE7393T1 (de) 1980-10-22 1981-10-15 Imidazo(1,2-a)pyridinderivate, verfahren zu ihrer herstellung und ihre therapeutische anwendung.

Country Status (22)

Country Link
US (2) US4382938A (de)
EP (1) EP0050563B1 (de)
JP (1) JPS5798283A (de)
AT (1) ATE7393T1 (de)
AU (1) AU544345B2 (de)
CA (1) CA1157470A (de)
DE (1) DE3163524D1 (de)
DK (1) DK154429C (de)
ES (1) ES8207537A1 (de)
FI (1) FI71143C (de)
FR (1) FR2492382A1 (de)
GR (1) GR74701B (de)
IE (1) IE51686B1 (de)
IL (1) IL64091A (de)
LU (1) LU88228I2 (de)
MX (1) MX6463E (de)
NL (1) NL930044I2 (de)
NO (1) NO155664C (de)
NZ (1) NZ198722A (de)
OA (1) OA07076A (de)
PT (1) PT73863B (de)
ZA (1) ZA817297B (de)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2525602A1 (fr) * 1982-04-21 1983-10-28 Synthelabo Imidazo(1,2-a)pyridines, leur preparation et leur application en therapeutique
FR2525601A1 (fr) * 1982-04-21 1983-10-28 Synthelabo Derives d'imidazo(1,2-a)pyridines, leur preparation et leur application en therapeutique
FR2568879B1 (fr) * 1984-08-07 1986-12-12 Synthelabo Imidazo(1,2-a)quinolines, leur preparation et leur application en therapeutique
FR2581646B1 (fr) * 1985-05-07 1987-09-18 Synthelabo Derives d'imidazopyridine, leur preparation et leur application en therapeutique
FR2593179B1 (fr) * 1986-01-22 1988-04-01 Synthelabo Derives d'imidazo(1,2-a)quinoleines, leur preparation et leur application en therapeutique
ATE62687T1 (de) * 1986-01-22 1991-05-15 Synthelabo Acylaminomethylimidazo(1,2-a>pyrimidinderivate, ihre herstellung und therapeutische verwendung.
FR2593817B1 (fr) * 1986-01-31 1988-04-15 Synthelabo Derives de tetrahydro-5,6,7,8 imidazo(1,2-a)pyridine, leur preparation et leur application en therapeutique
FR2599368B1 (fr) * 1986-06-02 1988-08-05 Synthelabo Derives hydroxyles d'imidazopyridines, leur preparation et leur application en therapeutique
FR2600650B1 (fr) * 1986-06-27 1988-09-09 Synthelabo Procede de preparation d'imidazopyridines et composes intermediaires
FR2606409B1 (fr) * 1986-11-07 1989-05-05 Synthelabo Derives d'imidazopyridine, leur preparation et leur application en therapeutique
FR2606411B1 (fr) * 1986-11-07 1989-04-07 Synthelabo Imidazopyridine-acetamides, leur preparation et leur application en therapeutique
FR2606410B1 (fr) * 1986-11-07 1989-02-24 Synthelabo Imidazopyridines, leur preparation et leur application en therapeutique
FR2612927B1 (fr) * 1987-03-27 1989-06-09 Synthelabo Derives d'imidazopyridines, leur preparation et leur application en therapeutique
EP0289371B1 (de) * 1987-03-27 1991-09-25 Synthelabo Imidazopyridinderivate, ihre Herstellung und therapeutische Verwendung
FR2612928B1 (fr) * 1987-03-27 1989-06-16 Synthelabo Derives hydroxyles d'imidazopyridines, leur preparation et leur application en therapeutique
US5032595A (en) * 1989-11-24 1991-07-16 Fidia-Georgetown Institute For The Neurosciences Method of stimulating steroidogenesis with alpidem
EP0809642A1 (de) * 1995-02-15 1997-12-03 PHARMACIA & UPJOHN COMPANY Imidazo (1,2-a) pyridine zur behandlung von zns und herzkrankheiten
IT1276522B1 (it) * 1995-04-07 1997-10-31 Elena Benincasa Uso dello zolpidem per il trattamento terapeudico di sindromi neuropsichiatriche associate a disfunsione e di circuiti neurali dei
US6013654A (en) * 1997-08-14 2000-01-11 Pharmacia & Upjohn Company Imidazo[1,2-A]pyridines for the treatment of CNS and cardiac diseases
AUPP278498A0 (en) 1998-04-03 1998-04-30 Australian Nuclear Science & Technology Organisation Peripheral benzodiazepine receptor binding agents
EP1005863A1 (de) * 1998-12-04 2000-06-07 Synthelabo Dosisformen mit gesteuerter Wirkstofffreigabe enthaltend ein kurzer wirkung Hypnotikum oder einem Salz davon
PT1038875E (pt) * 1999-03-25 2003-10-31 Synthon Bv Derivados de imidazopiridina e processo para os preparar
ATE297924T1 (de) * 1999-03-25 2005-07-15 Synthon Bv Zolpidem salze
US6333345B1 (en) 1999-05-14 2001-12-25 Sepracor, Inc. Methods of using and compositions comprising N-desmethylzolpidem
US6399621B1 (en) 1999-08-10 2002-06-04 American Cyanamid Company N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
US6485746B1 (en) 2000-08-25 2002-11-26 Neurocrine Biosciences, Inc. Controlled-release sedative-hypnotic compositions and methods related thereto
US20030091632A1 (en) * 1999-08-26 2003-05-15 Neurocrine Biosciences, Inc. Controlled-release sedative-hypnotic compositions and methods related thereto
US6384221B1 (en) * 1999-09-02 2002-05-07 Neurocrine Biosciences, Inc. Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
AU5066101A (en) * 2000-04-13 2001-10-30 Synthon B.V. Modified release formulations containing a hypnotic agent
CZ20023775A3 (cs) * 2000-04-24 2003-10-15 Teva Pharmaceutical Industries Ltd. Zolpidem hemitartrát
EP1475093B1 (de) 2000-04-24 2006-09-06 Teva Pharmaceutical Industries Ltd. Mikronisierter zolpidem Hemitartrat
AU2001264932A1 (en) * 2000-05-26 2001-12-11 Neurogen Corporation Oxo-imidazopyrimidine-carboxamides and their use as gaba brain receptor ligands
AU2001270297A1 (en) 2000-06-30 2002-01-14 Neurogen Corporation 2-phenylimidazo(1,2-a)pyridine derivatives: a new class of gaba brain receptor ligands
IT1318624B1 (it) 2000-07-14 2003-08-27 Dinamite Dipharma S P A In For Processo per la preparazione di 2-fenil-imidazo (1,2-a)piridin-3-acetammidi.
DE10040016A1 (de) * 2000-08-16 2002-02-28 Boehringer Ingelheim Pharma Neue beta-Amyloid Inhibitoren, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
US6514969B2 (en) * 2000-08-16 2003-02-04 Boehringer Ingelheim Pharma Kg β-amyloid inhibitors, processes for preparing them, and their use in pharmaceutical compositions
WO2002014306A1 (en) * 2000-08-17 2002-02-21 Cilag Ag Process for the preparation of imidazopyridines
AU2001284322A1 (en) * 2000-08-29 2002-03-13 Ranbaxy Laboratories Limited Synthesis of n,n-dimethyl-3-(4-methyl) benzoyl propionamide, a key intermediate of zolpidem
US6596731B2 (en) 2001-03-27 2003-07-22 Hoffmann-La Roche Inc. Substituted imidazo[1,2-A] pyridine derivatives
DE10117183A1 (de) * 2001-04-05 2002-10-10 Gruenenthal Gmbh Verwendung von substituierten Imidazo[1,2-a]-pyridinverbindungen als Arzneimittel
KR100433502B1 (ko) * 2001-10-10 2004-06-07 철 양 확장부가 형성된 종이컵
DE10247271A1 (de) * 2002-10-10 2004-08-26 Grünenthal GmbH Substituierte C-Imidazo[1,2-a]pyridin-3-yle
EP1575952B1 (de) * 2002-12-18 2009-02-18 Mallinckrodt Inc. Synthese von heteroaryl acetamiden
US20040204443A1 (en) * 2003-01-27 2004-10-14 Arthur Zaks Method for inducing pain relief using imidazo[1,2-a]pyridine derivatives
US20040241100A1 (en) * 2003-03-17 2004-12-02 Fabre Kramer Pharmaceutical, Inc. Nasally administrable compositions of zolpidem and methods of use
WO2005010002A1 (en) * 2003-07-31 2005-02-03 Ranbaxy Laboratories Limited Process for the synthesis of zolpidem
JP2007509960A (ja) * 2003-10-28 2007-04-19 セプラコア インコーポレーテッド イミダゾ［１，２−ａ］ピリジン抗不安薬
US20050176680A1 (en) 2003-12-11 2005-08-11 Sepracor, Inc. Combination of sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
JP5179757B2 (ja) * 2004-02-17 2013-04-10 トランセプト ファーマシューティカルズ， インコーポレイティド 口腔粘膜を介して催眠剤をデリバリーするための組成物及びその使用方法
WO2005079851A2 (en) 2004-02-18 2005-09-01 Sepracor, Inc. Dopamine-agonist combination therapy with sedatives for improving sleep quality
WO2006008636A2 (en) * 2004-07-16 2006-01-26 Ranbaxy Laboratories Limited Processes for the preparation of zolpidem and its hemitartrate
US20060084806A1 (en) * 2004-07-21 2006-04-20 Ramasubramanian Sridharan Processes for the preparation of imidazo[1,2-a] pyridine derivatives
FR2874611B1 (fr) * 2004-08-31 2006-11-17 Servier Lab Nouveaux derives d'imidazopyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP1883408A4 (de) * 2005-05-25 2009-11-11 Transcept Pharmaceuticals Inc Feste zusammensetzungen und verfahren zur behandlung von schlaflosigkeit mitten in der nacht
US20070287740A1 (en) * 2005-05-25 2007-12-13 Transcept Pharmaceuticals, Inc. Compositions and methods of treating middle-of-the night insomnia
US20070225322A1 (en) * 2005-05-25 2007-09-27 Transoral Pharmaceuticals, Inc. Compositions and methods for treating middle-of-the night insomnia
US20070020333A1 (en) * 2005-07-20 2007-01-25 Chin-Chih Chiang Controlled release of hypnotic agents
EP2258358A3 (de) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenese mit Acetylcholinesterasehemmer
EP1928437A2 (de) 2005-08-26 2008-06-11 Braincells, Inc. Neurogenese mittels muscarinrezeptormodulation
EP1940389A2 (de) 2005-10-21 2008-07-09 Braincells, Inc. Modulation von neurogenese durch pde-hemmung
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
AU2006322314A1 (en) 2005-11-18 2007-06-14 Synthon B.V. Zolpidem tablets
EP1803722A1 (de) 2006-01-03 2007-07-04 Ferrer Internacional, S.A. Imidazo[1,2-a]pyridin-3-yl-Essigsäure-Hydrazide, Verfahren zur ihrer Herstellung und ihre Verwendung als Arzneimittel
US8309104B2 (en) * 2006-03-02 2012-11-13 Watson Pharmaceuticals, Inc. Oral controlled release formulation for sedative and hypnotic agents
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP1845098A1 (de) * 2006-03-29 2007-10-17 Ferrer Internacional, S.A. Imidazo[1,2-b]pyridazinen, deren Herstellungverfahren und ihre Verwendung als GABA Rezeptor Liganden
WO2007134077A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
AU2007256893A1 (en) * 2006-06-05 2007-12-13 Auspex Pharmaceuticals, Inc. Preparation and utility of substituted imidazopyridine compounds with hypnotic effects
CN101528226B (zh) * 2006-08-24 2012-01-11 澳大利亚核科学技术组织 靶向外周苯二氮卓受体的氟化配体
EP2068872A1 (de) 2006-09-08 2009-06-17 Braincells, Inc. Kombinationen mit einem 4-acylaminopyridin-derivat
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20080145425A1 (en) * 2006-12-15 2008-06-19 Pliva Research & Development Limited Pharmaceutical composition of zolpidem
US20090076066A1 (en) * 2007-09-19 2009-03-19 Protia, Llc Deuterium-enriched zolpidem
TW200918102A (en) * 2007-10-24 2009-05-01 Nihon Mediphysics Co Ltd Novel compound having affinity for amyloid
US20090169618A1 (en) * 2007-12-26 2009-07-02 Limor Ari-Pardo Zolpidem pharmaceutical compositions
CA2732969A1 (en) * 2008-08-19 2010-02-25 The University Of Sydney Novel compounds and their uses in diagnosis
US10478438B2 (en) 2008-10-16 2019-11-19 David Reed Helton Treatment of organophosphate exposure with ocinaplon
WO2010074753A1 (en) 2008-12-23 2010-07-01 Map Pharmaceuticals, Inc. Inhalation devices and related methods for administration of sedative hypnotic compounds
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
WO2010122576A1 (en) 2009-04-20 2010-10-28 Matrix Laboratories Ltd Improved process for the preparation of 6-methyl-2-[4-methyl phenyl] imidazo [1, 2-a] pyridine-3-n, n-dimethyl acetamide.
JP5433508B2 (ja) * 2009-06-25 2014-03-05 高田製薬株式会社 ゾルピデム酒石酸塩含有内用液剤
CN102234275B (zh) * 2010-04-27 2015-12-16 溧阳合誉药物科技有限公司 治疗失眠的氘代咪唑并[1,2-a]吡啶衍生物、制备方法及其应用
US8741888B2 (en) 2010-11-09 2014-06-03 Carl A. Forest Sleep aid composition and method
IN2013MU02428A (de) * 2013-07-22 2015-06-19 3A Chemie Private Ltd
US10202376B2 (en) 2014-12-24 2019-02-12 Takeda Pharmaceutical Company Limited Heterocyclic compound
EP3468545A4 (de) 2016-06-08 2020-07-22 President and Fellows of Harvard College Verfahren und zusammensetzungen zur verringerung von taktiler dysfunktion und angst im zusammenhang mit autismus-spektrum-störungen, rett-syndrom und fragilem x-syndrom
US10807987B2 (en) * 2018-03-28 2020-10-20 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof
CA3099751A1 (en) 2018-05-22 2019-11-28 President And Fellows Of Harvard College Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment
EP3801512A4 (de) * 2018-05-29 2022-01-19 President and Fellows of Harvard College Zusammensetzungen und verfahren zur verminderung von taktiler dysfunktion, angst und sozialer beeinträchtigung
WO2020198275A1 (en) 2019-03-25 2020-10-01 President And Fellows Of Harvard College Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment
JP2021050161A (ja) 2019-09-25 2021-04-01 武田薬品工業株式会社 複素環化合物及びその用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3336194A (en) * 1963-04-30 1967-08-15 Merck & Co Inc Indolyl acid amides
GB1076089A (en) * 1965-11-09 1967-07-19 Selvi & C Lab Bioterapico New derivatives of imidazo [1,2-a]-pyridine and a process for the manufacture thereof

Also Published As

Publication number Publication date
JPS5798283A (en) 1982-06-18
NL930044I1 (nl) 1993-08-02
DK154429C (da) 1989-04-17
IL64091A (en) 1984-12-31
MX6463E (es) 1985-06-06
FI71143B (fi) 1986-08-14
PT73863A (fr) 1981-11-01
OA07076A (fr) 1984-01-31
JPS637545B2 (de) 1988-02-17
PT73863B (fr) 1983-11-07
FR2492382A1 (fr) 1982-04-23
NL930044I2 (nl) 1993-09-16
US4382938A (en) 1983-05-10
IE812470L (en) 1982-04-22
GR74701B (de) 1984-07-04
LU88228I2 (de) 1994-02-03
EP0050563B1 (de) 1984-05-09
EP0050563A1 (de) 1982-04-28
DK154429B (da) 1988-11-14
AU544345B2 (en) 1985-05-23
NZ198722A (en) 1984-10-19
DE3163524D1 (en) 1984-06-14
NO813551L (no) 1982-04-23
DK465181A (da) 1982-04-23
AU7668781A (en) 1983-04-28
IL64091A0 (en) 1982-01-31
NO155664B (no) 1987-01-26
ES506412A0 (es) 1982-09-16
US4460592A (en) 1984-07-17
FI71143C (fi) 1986-11-24
ES8207537A1 (es) 1982-09-16
IE51686B1 (en) 1987-02-04
ZA817297B (en) 1982-09-29
CA1157470A (en) 1983-11-22
NO155664C (no) 1987-05-06
FR2492382B1 (de) 1983-07-29
FI813288L (fi) 1982-04-23

Similar Documents

Publication Publication Date Title
ATE7393T1 (de) Imidazo(1,2-a)pyridinderivate, verfahren zu ihrer herstellung und ihre therapeutische anwendung.
AT385036B (de) Verfahren zum herstellen von neuen carboxamidoderivaten von 5h-1,3,4-thiadiazolo(3,2-a)-pyrimidinen und ihren pharmazeutisch unbedenklichen salzen
AT361486B (de) Verfahren zur herstellung von neuen imidazo(1,5 -a) (1,4)diazepinverbindungen, ihren salzen und optisch aktiven formen
PT76573B (fr) Procede de preparation de derives d'imidazo <1,2-a> pyridine et de compositions pharmaceutiques les contenant
AT375936B (de) Verfahren zur herstellung neuer pyrido-(1,2-a) pyrimidin-derivate sowie von deren salzen, solvaten, optisch aktiven antipoden, geometrischen und stereoisomeren und tautomeren
AT359506B (de) Verfahren zur herstellung von neuen, hetero- cyclischen pyrimido(1,2-a)-verbindungen und deren optisch aktiven isomeren
ATE147388T1 (de) Aminomethyl-substituierte 2,3-dihydropyrano(2,3- b)pyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3160044D1 (en) 2,3-dihydroimidazo (1,2-b) pyridazine derivatives, process for their preparation and their therapeutical use
AT381092B (de) Verfahren zur herstellung von neuen substituierten pyrrolo-(2,1-b)-chinazolinen und pyrido(2,1-b)- chinazolinen, ihren isomeren und deren gemischen und ihren pharmazeutisch unbedenklichen salzen
AT362377B (de) Verfahren zur herstellung neuer pyrido(1,2-a) pyrimidin-derivate, deren optisch aktiver isomere und physiologisch vertraeglicher salze
AT375937B (de) Verfahren zur herstellung von 9-hydrazono-6,7,8, 9-tetrahaydro-4h-pyrido (1,2-a) - pyrimidin-4-on- derivaten sowie von deren physiologisch vertraeglichen salzen, hydraten und isomeren
AT379395B (de) Verfahren zur herstellung von neuen 2(2-thienyl)-imidazo (4,5-b) pyridin-derivaten und deren pharmazeutisch vertraeglichen saeureadditionssalzen
AT377521B (de) Verfahren zur herstellung von neuen pyrido(2,3-e)-as-triazin-derivaten und deren pharmazeutische geeigneten saeureadditionssalzen
ATA182780A (de) Verfahren zur herstellung neuer pyrido-(1,2-a) pyrimidin-derivate, deren optisch aktiver isomerer und physiologisch vertraeglicher salze
ATA182680A (de) Verfahren zur herstellung neuer pyrido-(1,2-a) pyrimidin-derivate, deren optisch aktiver isomeren und physiologisch vertraeglichen salze
DK0399653T3 (da) Triazolo(4,5-c)pyridinderivater med antikrampe virkning